BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for Palvella Therapeutics, Inc. (PVLA)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Palvella Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-12-17
5:42 pm
Purchase		 2024-12-13 13G Palvella Therapeutics, Inc.
PVLA		 BIOTECHNOLOGY VALUE FUND L P 1,168,117
9.990%		 1,168,117increase
(New Position)		 Filing